.
The (Hayden, 1981 (Conneally, 1984) . In approximately 10% of cases the disease begins before the age of 20 years. A large proportion of such cases show a rigid parkinsonian form of the disease and have a more rapid clinical decline than the typical adult onset form. One intriguing and unexplained as-pect of juvenile onset HD is the large excess of paternal transmission.
In cases with juvenile onset, the father is approximately four times as likely to be affected than the mother (Merritt et al., 1969) .
Although invariably fatal, HD is the underlying rather than the immediate cause of death in patients. The most common primary causes of death are heart disease and aspiration-induced pneumonia (Haines and Conneally, 1986) . Approximately 6% of HD patients in the United States commit suicide and 28% attempt suicide at least once (Farrer, 1986) .
The basic gene defect in HD is unknown. Extensive neuropathological and neurochemical studies in HD (Martin and Gusella, 1987) reveal localized neuronal loss, particularly in the striatum, and decreases in the levels of a number of neurotransmitters in specific brain areas. Therapeutic strategies aimed at transmitter replacement have not been successful.
The discovery of the probe GB, which identifies the DNA marker D4SlO linked to the HD gene (Gusella et al., 1983) , has introduced the possibility of cloning the mutant gene and developing effective therapeutic interventions based on an understanding of the gene defect. Closely linked DNA markers have also made presymptomatic and prenatal diagnostic testing now available. Given the late onset of the disorder and its severity, many at-risk individuals have expressed interest in a presymptomatic test which has both advantages and disadvantages:
it can assist in planning but is an inevitably fatal diagnosis with no treatment available. Since the majority of HD gene carriers are born while their heterozygous parents are still asymptomatic, at-risk individuals would like to use prenatal diagnosis to ensure that, regardless of whether they carry the HD gene, they will have children who are free of the disease .
Presymptomatic and prenatal diagnoses rely on observing D4S10, the DNA marker closely linked to the HD gene. For the accuracy of this test, it is imperative that only one HD locus exist, or, if there is locus heterogeneity, that it can be recognized. An intensive effort has therefore been made to obtain a large number of informative HD families from as many ethnic and racial backgrounds as possible to test for locus heterogeneity.
MATERIALS AND METHODS
Families with a documented history of HD were ascertained. Those whose structures were deemed suitable for linkage analysis were invited to participate. A total of 63 families were examined for linkage between the HD gene and D4SlO. Four were American Black, two were Oriental (Japanese), and the remainder were Caucasian from different parts of the world. Procedures were the same in the analyses of all families, although some families had DNA typing for more RFLPs than others, as new markers were developed. DNA was prepared directly from peripheral blood lymphocytes, from fibroblasts, or from Elpstein-Barr virus-transformed lymphoblastoid cell lines. Lymphoblast DNA was prepared using methods described elsewhere (Gusella et al., 1979) .
The D4SlO locus probes G8, R7, pk082, and pk083 and the resulting polymorphisms have been previously described . The probes were labeled with 32P following the procedure of Feinberg and Vogelstein (1983) . Filters were prehybridized and hybridized as described in G-usella et al. (1983) . The filters were washed under con.ditions equal to 0.1 X SSC, 0.1% SDS at 65°C; results were obtained by autoradiography at -70°C for 1-5 days.
Two-point linkage analysis was carried out using the program LIPED version 3 (Ott, 1974) , and multipoint linkage analysis using t.he program package LINKAGE (version 3.5) described by Lathrop et al. (1984) . Atrisk individuals were assigned a probability of carrying the HD gene based on a cumulative age-of-onset distribution from data on 999 affected individuals from the National Hunting&m's Disease Research Roster at Indiana University. The probability that the offspring of an affected individua.l is asymptomatic at age i, given that he or she is heterozygous for the HD gene, is 1 -Yi where Yi is the cumulative probability of being affected by age i . Asymptomatic individuals under age 30 were not used in the linkage analysis, since they contribute little information on linkage and the authors did not want to discover genotypes of presymptomatic individuals. Occasionally, genotype data from at-risk persons were needed to reconstruct parental haplotypes; all such information was maintained in the laboratory under code, was accessed by only the absolute minimum number of investigators needed to analyze the data, and was not revealed to the family. The participating families knew in advance that these were research studies only and that they would not be provided with diagnostic feedback since it is important that diagnostic information be provided in the context of intensive counseling and follow-up support. Individuals we.re told that HD in their families was found to be linked to D4SlO and whether they were genetically informlative, if they requested this information.
The existence of linkage heterogeneity, i.e., the possibility of more than one locus being involved in the etiology of HD, was tested using the program HOMOG (Ott, 1985 , using the method of Smith, 1963) . This program allows for three alternatives for explaining the data: (i) two loci, one linked and one unlinked; (ii) the same as (i) but including a possible sex difference in recombination frequencies; and (iii) two loci, both linked, but. with different recombination frequencies. The program output provides confidence intervals for the proportion of linked families. The 99% confidence interval for the recombination frequency 8 is obtained by drawing a horizontal line 2 lod scores below the peak lod score on the lod score curve, as shown in Fig. 1 . The two points of intersect,ion between the straight line and the lod score curve mark the two endpoints of the confidence interval (Conneally et al., 1985) . IO Evidence for significant disequilibrium between the HD and D4SlO loci would suggest a very limited number of different mutational events at the HD locus. If the marker locus is very close to the HD locus, one would expect that a specific haplotype(s) would be traveling with the HD gene much more frequently than would be expected if the two loci were independent of one another.
The Hind111 endonuclease cuts at two polymorphic sites with the D4SlO locus, giving four haplotypes: A, B, C, and D (Gusella et al., 1983) . EcoRI cuts at one variable site with two alleles, 1 and 2. In a total of 44 families, the HindIII-EcoRI combined haplotypes traveling with the HD gene could be determined. Control haplotype frequencies were determined from a group of individuals without the HD allele.
RESULTS
The lod scores for the 63 families for recombination values (8) from 0 to 10 CM together with the maximum lod score and its corresponding recombination frequency, are summarized in Table 1 . The combined maximum lod score was 87.69 at 8 = 0.04. This is shown graphically in Fig. 1 . The 99% confidence interval for 8 is 0.018 to 0.071. Additionally, joint lod scores were obtained where male and female recombination frequencies were allowed to vary from each other. The maximum frequency of recombination in males was 0.03 with 95% confidence intervals of 0.01 and 0.07. The maximum frequency in females was 0.05 with 95% confidence interva+ of 0.02 and 0.08. The peak lod score at 8 M = 0.03, @r = 0.05 was 87.74. This is shown graphically in Fig. 2 .
Five of the 63 families had negative lod scores, all of which were relatively small. The values were never below -2 within the confidence interval for 8. Therefore, the HD gene in these families could not be assumed to be at an alternate location.
There was no evidence for locus heterogeneity; that is, one linked and one unlinked locus, among these analyzed families. The maximum likelihood estimate of cr, the proportion of linked loci, was 1.0, with a lower 99% confidence interval of 0.88. When the possibility of two linked loci was tested, the program HqMOG gave maximum likelihood estimates of 0.02 for 8, and 0.04 for 8,. However, these estimates were not significantly different from the one-locus hypothesis (x" = 0.08, P > 0.48). Table 2 shows the distribution of G8 haplotypes for Hind111 and EcoRI combined among the HD families. There are no significant differences between the haplotypes of those affected with HD and the haplotypes of normal controls (X&j = 6.53, P > 0.40). Thus, t,here is no evidence for genetic disequilibrium between the D&IO and the HD loci.
DISCUSSION
The discovery of a genetic marker linked to the gene for Huntington disease should eventually lead to the cloning of the mutant gene and characterization of its defect. A more immediate outcome of the finding is the capacity for presymptomatic and prenatal identification of gene carriers. These preclinical tests have been described in detail elsewhere (Meissen et al., 1988) . It is imperative that presymptomatic testing for the presence of HD in asymptomatic individuals be delivered as accurately as possible. Catastrophic consequences could result from erroneous test results, particularly a false positive test, where an individual is informed that he or she is at high risk for carrying the HD gene when, in fact, the person is homozygous for the normal non-HD allele. Informed genetic counseling for presymptomatic testing is not possible in the absence of thorough information regarding nonallelic heterogeneity for the HID locus. If locus heterogeneity existed, the predictive test would not be useful in those families where the HD mutation occurred at a locus unlinked to the current, markers. Unfortunately, the only way to definitively rule out locus heterogeneity is to perform a full linkage analysis on each family desiring testing, but this is usually not feasible, since large informative families are not common. In fact, only 40% of at-risk individuals listed in the National Huntington's Disease Research Floster have the minimal family structure needed for an informative "predictive" test (as few as t,wo to three relatives sufficient, to establish the phase of the marker with respect to the disease allele in the given family).
Fortunately, as the results of these analyses show, it is likely that only one locus for HD exists. The 99% lower confidence interval for the proportion of linked families is 88%. This is a conservative estimate, especially since there is no' significant evidence that any of the families are unlin.ked to LMSlO. While it is still possible that an HD mutation might occur at another site, at best it would appear to be a rare occurrence which should have minimal effect on the conduct of predictive testing. If a family in which the HD allele does not appear to be nea.r the telomere of chromosome 4 is located, all diagnoses must be scrupulously reconfirmed by clinicians blind to t.he genotypes, and neuropathological analyses of postmortem brain tissue should be sought. A precise estimate of the recombination fraction is also important for accurate prediction and for estimating the approximate distance in kilobases of the marker from the HD locus. Although the data suggest that the recombination frequency in females is greater than that in males (0.05 vs 0.03), this is not significant, and it is reasonable to use the overall estimate of 4 CM as the distance between the marker and the gene.
The test for linkage disequilibrium between D4SlO and the HD locus showed no significant difference from that of controls. This is not surprising, considering that the two loci are 4 CM apart. If, as is suspected, the HD mutation is ancient, there would have been sufficient time for the two loci to have reached approximate equilibrium.
